Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Stewart Information Services
STC
$2.08B
| $5.42M | 0.01% |
143,573
+26,735
| +23% | +$1.04M |
|
|
TSG
1627
DELISTED
The Stars Group Inc.
TSG
| $5.42M | 0.01% |
264,269
+171,380
| +184% | +$3.09M |
|
|
AEL
1628
DELISTED
American Equity Investment Life Holding Company
AEL
| $5.41M | 0.01% |
186,121
+173,171
| +1,337% | +$4.78M |
|
1629
Provident Financial Services
PFS
$3.19B
| $5.41M | 0.01% |
202,702
+52,503
| +35% | +$1.33M |
|
|
MZTI
1630
The Marzetti Company
MZTI
$3.11B
| $5.37M | 0.01% |
44,687
-148,994
| -77% | -$18M |
|
|
SCS
1631
DELISTED
Steelcase
SCS
| $5.36M | 0.01% |
+347,989
| New | +$4.77M |
|
|
ISBC
1632
DELISTED
Investors Bancorp, Inc.
ISBC
| $5.34M | 0.01% |
391,580
+39,329
| +11% | +$519K |
|
|
TRTN
1633
DELISTED
Triton International Limited
TRTN
| $5.33M | 0.01% |
+160,309
| New | +$5.52M |
|
1634
CALL
Vertex Pharmaceuticals
VRTX
$126B
| $5.32M | 0.01% |
35,000
-95,000
| -73% | -$14.3M |
|
|
IVAC
1635
DELISTED
Intevac Inc
IVAC
| $5.32M | 0.01% |
629,480
+310,881
| +98% | +$3.03M |
|
1636
PUT
Prudential Financial
PRU
$41.8B
| $5.32M | 0.01% |
50,000
-10,000
| -17% | -$1.07M |
|
|
1637
CALL
British American Tobacco
BTI
$128B
| $5.31M | 0.01% |
+85,000
| New | +$5.48M |
|
1638
Prudential
PUK
$35.2B
| $5.31M | 0.01% |
+114,232
| New | +$5.22M |
|
1639
Insmed
INSM
$28.6B
| $5.3M | 0.01% |
169,821
+156,229
| +1,149% | +$2.98M |
|
1640
iShares TIPS Bond ETF
TIP
$14.5B
| $5.29M | 0.01% |
+46,536
| New | +$5.3M |
|
1641
Children's Place
PLCE
$59.8M
| $5.28M | 0.01% |
44,694
-114,803
| -72% | -$12.3M |
|
1642
Celldex Therapeutics
CLDX
$3.27B
| $5.26M | 0.01% |
122,704
+112,385
| +1,089% | +$4.21M |
|
1643
Old National Bancorp
ONB
$10.2B
| $5.26M | 0.01% |
287,286
+263,200
| +1,093% | +$4.4M |
|
1644
Beazer Homes USA
BZH
$907M
| $5.24M | 0.01% |
279,847
+227,936
| +439% | +$3.47M |
|
|
ACRE
1645
Ares Commercial Real Estate
ACRE
$270M
| $5.24M | 0.01% |
393,754
+239,465
| +155% | +$3.14M |
|
|
TIME
1646
CALL
DELISTED
Time Inc.
TIME
| $5.24M | 0.01% |
+387,900
| New | +$5.21M |
|
1647
First Busey Corp
BUSE
$2.58B
| $5.23M | 0.01% |
166,834
+136,723
| +454% | +$4M |
|
1648
Lesaka Technologies
LSAK
$420M
| $5.22M | 0.01% |
536,049
+189,356
| +55% | +$1.83M |
|
1649
PTC Therapeutics
PTCT
$6.12B
| $5.21M | 0.01% |
+260,633
| New | +$5.1M |
|
|
MRTX
1650
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.21M | 0.01% |
445,709
+227,719
| +104% | +$1.32M |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.